ETA
6.3.2024 13:41:28 CET | Business Wire | Press release
Cairo is transforming into a long weekend hotspot with the new City Break initiative, announced H.E. Ahmed Issa, the Minister of Tourism and Antiquities of Egypt at ITB Berlin 2024.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240306125956/en/
Minister Ahmed Issa at press conference, ITB Berlin 2024 (Photo: Business Wire)
Cairo City Break Program and A New Era of Luxury Tourism
The new Cairo City Break program is aimed at transforming the capital into a dynamic, must-visit long weekend destination. The visitors will have the opportunity to explore many tourist and archaeological sites by offering diverse and varied tourist experiences encompassing various historical and cultural places, whether Pharaonic, Coptic, or Islamic.
This will contribute to increasing the number of tourist nights spent in Cairo from an average of three to four days to 12 days.
“There is no other city that can offer visitors monuments from every great civilization starting from 3500 B.C. We are dedicated to turning Cairo into a destination that can be enjoyed over the span of multiple visits or a long weekend,” stated the Minister of Tourism and Antiquities, H.E. Ahmed Issa.
Egypt has also been actively developing emerging destinations and elevating traveler's experience at archaeological sites by introducing new destinations and improved, faster, and environmentally friendly ways of commute to key destinations such as Luxor. For instance, in Q4 2025/Q1 2026 Hurghada and Luxor will be connected by a high-speed train.
A Transformative Reform and Infrastructure Development
Egypt's tourism industry is undergoing a transformative reform towards deregulation, paving the way for new investors, and redefining the relationship between the government and the private sector. In tandem with the reform, Egypt’s strategic deregulation efforts and the allocation of 22% of GDP to infrastructure development over the past seven years are paying off, demonstrating a strong commitment to boosting the country's global tourism reputation. The aim is to double Egypt's hotel capacity to 60,000 rooms within the next five years.
Record-Breaking Tourism Results and Main Travel Trends
Egypt witnessed an extraordinary surge in tourism during 2023, with a record 14.906 million visitors gracing its shores — an exponential increase from the 4.9 million recorded in 2021.
This upward trend is expected to continue in 2024, with a remarkable 8% year-on-year growth in the first 50 days of the year. Most visitors come from Germany, with 1.6 million tourists recorded last year, followed by Russia, Saudi Arabia, Italy, and the United Kingdom.
About the Egyptian Tourism Authority
Established in 1981, the Egyptian Tourism Authority is dedicated to promoting Egypt's vast historical assets and diverse destinations, fostering domestic tourism, and connecting Egyptians with their rich heritage. Under the leadership of the Minister of Tourism, the Egyptian Tourism Authority spearheads marketing strategies, supports tourism development, and sponsors various events to enhance Egypt's tourism industry.
For more information, visit Experience Egypt.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240306125956/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 01:00:00 CEST | Press release
-Once-daily oral ALK2 inhibitor approved to reduce the volume of total new heterotopic ossification in patients aged 12 years and older with FOP-Atebrioz expected to be available in the United States in October through Mirum Access Plus (MAP), with eligible patients paying as little as $0 per month-PROGRESS pediatric development program continues to evaluate zilurgisertib in children aged 2 to <12 years Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for pe
Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 21:19:00 CEST | Press release
The offtake agreement connects Digital Reef’s 3.3 GW data centre pipeline with environmental assets from more than 30 million hectares of Amazon rainforest across South America, where Oreasoc Agriculture works directly on the ground alongside local communities to develop sustainable economies and safeguard their territories. Xange.com’s digital MRV technology monitors both the data centres and the rainforest. At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where D
NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 15:00:00 CEST | Press release
Planned acquisition strengthens NetApp's position in the rapidly growing AI infrastructure market by bringing differentiated metadata innovation and parallel file architecture designed for AI NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata fr
MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 14:57:00 CEST | Press release
The Group was recognised for the strength of its global institutional ecosystem and its contribution to financial markets innovation and community impact MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity
Croma-Pharma Introduces saypha® volume prime Lidocaine25.9.2026 14:04:00 CEST | Press release
New cross-linked hyaluronic acid filler replaces saypha® volume Lidocaine, offering physicians a more versatile solution for both midface volumization and nasolabial folds Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
